S
VRTX icon

Sachetta’s Vertex Pharmaceuticals VRTX Stock Holding History

Sachetta’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-49
Closed -$21.9K – 1220
2026
Q1 		$21.9K Hold
49
– – 0.01% 293
2025
Q4 		$22.2K Hold
49
– – 0.01% 283
2025
Q3 		$19.2K Sell
49
-56
-53% -$23.4K 0.01% 367
2025
Q2 		$46.7K Sell
105
-13
-11% -$5.99K 0.02% 263
2025
Q1 		$57.2K Buy
118
+10
+9% +$4.66K 0.02% 241
2024
Q4 		$43.5K Sell
108
-90
-45% -$41.7K 0.02% 279
2024
Q3 		$92.1K Buy
198
+54
+38% +$25.9K 0.04% 211
2024
Q2 		$72.4K Buy
144
+17
+13% +$7.38K 0.03% 217
2024
Q1 		$51.7K Hold
127
– – 0.02% 244
2023
Q4 		$51.7K Buy
+127
New +$46.9K 0.02% 244

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
MLL
Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Sachetta's VRTX Position: Q2 2026 in Review

Sachetta sold out of Vertex Pharmaceuticals (VRTX) in Q2 2026, closing a stake of 49 shares — an estimated $21.9K sold.

Sachetta first reported a position in VRTX in Q4 2023 and held it in 10 quarters. The position peaked at $92.1K in Q3 2024. 296 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Sachetta reported no remaining Vertex Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Sachetta sold 49 Vertex Pharmaceuticals shares in Q2 2026, an estimated $21.9K.
  • Sachetta first reported a position in Vertex Pharmaceuticals in Q4 2023 and held it in 10 quarters.
  • Sachetta's Vertex Pharmaceuticals position peaked at $92.1K in Q3 2024.
  • 296 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.